PRNewsWire
20 Jul 2026, 20:45 UTC · 10h ago
Cardinal Health expands home care business with two tuck-in acquisitions
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

PRNewsWire
20 Jul 2026, 20:45 UTC · 10h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Cardinal Health is acquiring AdaptHealth's Diabetes Health business and Strive Medical for approximately $360 million in cash. — The acquisitions expand the company's footprint in the home care market and represent a material cash outlay for growth.
+0.30The transactions are expected to be accretive to non-GAAP earnings per share within the first 12 months following closing. — Immediate EPS accretion is a positive signal for shareholders regarding the valuation and efficiency of the deal.
+0.20Cardinal Health is scaling its at-Home Solutions business by adding capabilities in diabetes management and urology. — Diversification into specific therapeutic categories reduces reliance on broader distribution and captures higher-margin specialty services.
+0.10Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is expanding its home care business through strategic acquisitions expected to be accretive to earnings.
The company is receiving a cash infusion from the sale of its Diabetes Health business.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
13h ago